MicroRNA-98 sensitizes cisplatin-resistant human lung adenocarcinoma cells by up-regulation of HMGA2

Pharmazie

Volumn 68, Issue 4, 2013, Pages 274-281

  Xiang, Qiong ^a   Tang, Huifang ^a   Yu, Jia ^a   Yin, Jie ^a   Yang, Xiaoyan ^a   Lei, Xiaoyong ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; HIGH MOBILITY GROUP A2 PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 98; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; DRUG SENSITIZATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; UPREGULATION;

ANTINEOPLASTIC AGENTS; BCL-X PROTEIN; BLOTTING, WESTERN; CELL LINE, TUMOR; CISPLATIN; COLORING AGENTS; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GENETIC VECTORS; HMGA2 PROTEIN; HUMANS; IN SITU HYBRIDIZATION; LUCIFERASES; MICRORNAS; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES; TRANSFECTION;

EID: 84876229388     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.2759     Document Type: Article

References (34)

1. Adams JM, Cory S (1998) The Bcl-2 protein family: Arbiters of cell survival. Science 281: 1322-1326.
2. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355.
3. Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z, Liu CG, Reinhold W, Lorenzi PL, Kaldjian EP, Croce CM, Weinstein JN, Sadee W (2007) MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 6: 1483-1491.
4. Boo LM, Lin HH, Chung V, Zhou B, Louie SG, O'Reilly MA, Yen Y, Ann DK (2005) High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation. Cancer Res 65: 6622-6630.
5. Calin GA, Croce CM (2006) MicroRNA signatures in human cancer. Nat Rev Cancer 6: 857-866.
6. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004.
7. Castoldi M, Schmidt S, Benes V, Noerholm M, Kulozik AE, Hentze MW, Muckenthaler MU (2006) A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA 12: 913-920.
8. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAsmodulate hematopoietic lineage differentiation. Science 303: 83-86.
9. Du T, Zamore PD (2005) microPrimer: the biogenesis and function of microRNA. Development 132: 4645-4652.
10. Esquela-Kerscher A, Slack FJ (2006) Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
11. Harfe BD (2005) MicroRNAs in vertebrate development. Curr Opin Genet 15: 410-415.
12. Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ (2007) High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 6: 5.
13. Henschke CI,YankelevitzDF(2008)CTScreening for Lung Cancer: Update 2007. Oncologist 13: 619.
14. Huang Z, Lei X, ZhongM,Zhu B,Tang S, LiaoD(2007) Bcl-2 small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells. Acta Biochim Biophys Sin 39: 835-843.
15. HwangHW, Mendell JT (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780.
16. Karczmarek-Borowska B, Filip A,Wojcierowski J, Smole'n A, Korobowicz E, Korszen-Pilecka I, Zdunek M (2006) Estimation of prognostic value of Bcl-XL gene expression in non-small cell lung cancer. Lung Cancer 51: 61-69.
17. Krek A, Grun D, PoyMN,Wolf R, RosenbergL, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N (2005) Combinatorial microRNA target prediction. Nat Genet 37: 495-500.
18. Lei X, Huang Z, Zhong M, Zhu B, Tang S, LiaoD(2007) Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells. Acta Biochim Biophys Sin 39: 344-350.
19. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
20. Li Z, Lu J, Sun M, Mi S, Zhang H, Luo RT, Chen P, Wang Y, Yan M, Qian Z, Neilly MB, Jin J, Zhang Y, Bohlander SK, Zhang DE, Larson RA, Le Beau MM, Thirman MJ, Golub TR, Rowley JD, Chen J (2008) Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A 105: 15535-15540.
21. Lin YC, Kuo MW, Yu J, Kuo HH, Lin RJ, Lo WL, Yu AL (2008) c- Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. Mol Biol Evol 25: 2189-2198.
22. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet- Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
23. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma celllines. Gastroenterology 130: 2113-2129.
24. Nishio K, Nakamura T, Koh Y, Suzuki T, Fukumoto H, Saijo N (1999) Drug resistance in lung cancer. Curr Opin Oncol 11: 109-115.
25. Rossi L, Bonmassar E, Faraoni I (2007) Modification ofmiRgene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol Res 56: 248-253.
26. Sarhadi VK, Wikman H, Salmenkivi K, Kuosma E, Sioris T, Salo J, Karjalainen A, Knuutila S, Anttila S (2006) Increased expression of high mobility group A proteins in lung cancer. J Pathol 209: 206-212.
27. Sgarra R, Rustighi A, Tessari MA, Di Bernardo J, Altamura S, Fusco A, Manfioletti G, Giancotti V (2004) Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett 574: 1-8.
28. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY (2007) miR-21-mediated tumo growth. Oncogene 26: 2799-2803.
29. Tahir SK, Yang X, Anderson MG, Morgan-Lappe SE, Sarthy AV, Chen J, Warner RB, Ng SC, Fesik SW, Elmore SW, Rosenberg SH, Tse C (2007) Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737. Cancer Res 67: 1176-1183.
30. Tessema M, Belinsky SA (2008) Mining the epigenome for methylated genes in lung cancer. Proc Am Thorac Soc 5: 806-810.
31. Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: MicroRNAs can up-regulate translation. Science 318: 1931-1934.
32. Wu W, Sun M, Zou GM, Chen J (2007) MicroRNA and cancer: current status and prospective. Int J Cancer 120: 953-960.
33. Yu L, Wang Z (2004) Difference in expression of Bcl-2 and Bcl-XL genes in cisplatin-sensitive and cisplatin-resistant human in ovarian cancer cell lines. J Huazhong Univ Sci Technolog Med Sci 24: 151-153.
34. Zhang B, Farwell MA (2008) microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 12: 3-21.